Microbot Medical
MBOT
24 hedge funds and large institutions have $2.33M invested in Microbot Medical in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 5 closing their positions.
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
25% more capital invested
Capital invested by funds: $1.87M → $2.33M (+$463K)
14% more funds holding
Funds holding: 21 → 24 (+3)
0.31% more ownership
Funds ownership: 0.08% → 0.39% (+0.31%)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$4.73M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$421K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$90.3K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$75.8K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$15.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$511K |
| 2 |
Goldman Sachs
New York
|
-$96K |
| 3 |
D.E. Shaw & Co
New York
|
-$69K |
| 4 |
BlackRock
New York
|
-$18.8K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$14.7K |
MBOT Hedge Fund Activity: Q2 2017 in Review
24 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2017, worth a combined $2.33M — up 25% from $1.87M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new MBOT positions and 5 closed out — a net gain of 3 holders — while 2 added to existing stakes and 6 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $4.73M. The largest seller was Millennium Management, exiting entirely with an estimated $511K sold.
- 24 institutional investors held Microbot Medical (MBOT) as of Q2 2017, up from 21 in Q1 2017.
- Funds reported $2.33M of Microbot Medical stock for Q2 2017, up 25% quarter-over-quarter.
- 8 funds opened new Microbot Medical positions in Q2 2017 and 5 closed out, a net change of +3 holders.
- The largest Microbot Medical buyer in Q2 2017 was Sabby Management, an estimated $4.73M added.
- The largest Microbot Medical seller in Q2 2017 was Millennium Management, an estimated $511K sold.
Based on aggregated 13F filings for Q2 2017.